This summer, the Pulmonary Vascular Research Institute (PVRI) celebrates its ten-year anniversary. The bold mission of the PVRI is: "to reduce the global burden of pulmonary vascular disease within the next two decades." The PVRI has three primary objectives: to improve the care of patients all over the world who suffer from pulmonary vascular disease; to facilitate and accelerate research in the clinical and basic science of the disease; and to encourage the development of new therapies. Timely publication of new advances in basic, translational, and clinical research on pulmonary vascular disease is a critical way to achieve these objectives.

The PVRI's early foray into publishing was the *Textbook of Pulmonary Vascular Disease*, edited by Jason X.-J. Yuan, Joe G.N. Garcia, Charles A. Hales, Stuart Rich, Stephen L. Archer, and John B. West. Writing and editing began in 2008; Springer published the textbook in 2011. This book combines basic scientific knowledge on the pulmonary circulatory system at levels of the molecule, cell, tissue, and organ with clinical diagnosis and treatment of pulmonary vascular diseases. State-of-the-art techniques and their potential applications in research, diagnosis, and treatment of pulmonary vascular diseases are also explained. A second edition of the book is in the planning stage now.

When members of the PVRI launched the journal in 2011, no one knew what to expect. Were there enough researchers in clinical science, basic science, and translational science to support a new journal exclusively focused on the pulmonary circulation and pulmonary vascular disease? The answer is now a resounding "yes!"

After six and a half years, over 600 submissions, over 500 published articles, and over 100,000 PDF-article downloads, *Pulmonary Circulation* has proven its ability to capture some of the best original research and comprehensive reviews in the field. The journal has a global reach with authors from more than 65 different countries. Our goal was that *Pulmonary Circulation* would become *the* valued journal in the field. We believe we are well on the way to achieving that goal.

This year, in Volume 7 of the journal, we are on track to publish more original research articles and reviews per issue, when compared with previous volumes. The editorial leadership team has been busy with more manuscripts submitted than in the past. This means many of you on the Editorial Board will receive more invitations to review manuscripts and support the continuing growth of the journal. We count on timely reviews to show authors that we are committed to a rapid response to their manuscripts. We count on our Editorial Board members to support the journal by submitting manuscripts to and reviewing manuscripts for the journal, reading and citing the published articles in the journal, and recommending the journal to colleagues and students.

*Pulmonary Circulation* will receive its first impact factor from Thomson Reuters this summer. The impact factor is a measure of a journal's citation influence in the broader literature. First, thank you to all who have submitted manuscripts to the journal, encouraged your colleagues to submit manuscripts, and read the journal. We also express thanks to authors who have cited research published in *Pulmonary Circulation*; our first impact factor will reflect the depth, breadth, and quality of the journal.

Again, we look to you, our readers and contributors, to help sustain the journal and take us to the next level. Please submit to us your most novel and significant original research articles in basic, translational, and clinical research; your comprehensive review articles on interesting topics related to pulmonary vascular disease; your highly novel (and rare) case reports; and your Leading Edge Perspectives (a new type of manuscript the editorial office is soliciting). Our Submissions Guidelines page outlines the requirements for each article type: <https://us.sagepub.com/en-us/nam/pulmonary-circulation/journal202599#submission-guidelines>.

As we look ahead to the next decade with the Pulmonary Vascular Research Institute, we are grateful to all who support the journal---PVRI members, editorial board members, authors, and readers---for helping establish our unique voice within the world of medical publishing.
